Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms

•Respiratory samples collected from ICU hospitalized patients are heterogeneous.•The virus-over-cell ratio in respiratory samples allows some standardization of influenza virus load measurement.•Standardized respiratory viral load could help predicting poor outcome in patients with acute respiratory...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical virology 2021-03, Vol.136, p.104761-104761, Article 104761
Hauptverfasser: Pronier, Charlotte, Gacouin, Arnaud, Lagathu, Gisèle, Le Tulzo, Yves, Tadié, Jean-Marc, Thibault, Vincent
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 104761
container_issue
container_start_page 104761
container_title Journal of clinical virology
container_volume 136
creator Pronier, Charlotte
Gacouin, Arnaud
Lagathu, Gisèle
Le Tulzo, Yves
Tadié, Jean-Marc
Thibault, Vincent
description •Respiratory samples collected from ICU hospitalized patients are heterogeneous.•The virus-over-cell ratio in respiratory samples allows some standardization of influenza virus load measurement.•Standardized respiratory viral load could help predicting poor outcome in patients with acute respiratory distress syndrome. The link between influenza virus (IV) viral load (VL) in respiratory samples and disease severity is not clearly established. This study was designed to assess IV-VL in respiratory samples from flu patients admitted to intensive care unit (ICU). Patients admitted to ICU for IV infection, as documented by RT-PCR, with respiratory failure were included in the study during 5 flu-seasons (2014–2018). Routine ICU management parameters were recorded. Real-time amplification Ct-values for IV and cell GAPDH gene were measured in each respiratory sample collected at ICU admission. Among 105 included patients, 59 (56.1%) presented an acute respiratory distress syndrome (ARDS). The overall mortality was 21%. IV-load assessed by amplification Ct-values and virus-over-cell ratio (expressed as log10) in each respiratory sample ranged from 20 to 40 and −5.2–3.7, respectively, and did not differ according to the type of sample and IV-A or -B type. Cell richness was higher in samples from ARDS patients compared to non-ARDS (p = 0.0003) but no difference was noted for IV Ct-values. In ARDS-patients, IV Ct-values (p = 0.020) and the virus-per-cell ratio (p = 0.038) were significantly higher in sample from patients who eventually died compared to those who survived. These 2 parameters remain independently associated with mortality with an odd-ratio of 1.21 and 2.19, respectively (p 
doi_str_mv 10.1016/j.jcv.2021.104761
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03156480v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1386653221000287</els_id><sourcerecordid>2491949814</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-afa59994ca2338493843432b95807af196a8f24afddc877c918fe6eadbefa5d53</originalsourceid><addsrcrecordid>eNp9kcFvFCEYxYmxsbX6B3gxHPUwKwwMA_HUNGqbbGJi2jP5lvmwrDPDCLNjtn-9bKb26IEAX37vBd4j5B1nG864-rTf7N2yqVnNy122ir8gF1y3omqMal-Ws9CqUo2oz8nrnPeM8UbI9hU5F0IxY4S8IPYH5ikkmGM60tvR9wccH4EuZdTTPkJHIVOgA6RfmGj0dIox0SnFn2PMIdMw0gnmgOOc6Z8wP9CMCyak-ThMcxzyG3Lmoc_49mm_JPdfv9xd31Tb799ur6-2lZOCzRV4aIwx0kEthJamLCFFvTONZi14bhRoX0vwXed02zrDtUeF0O2wKLtGXJKPq-8D9HZKoTz4aCMEe3O1tacZE7xRUrOFF_bDypZv_D5gnu0QssO-hxHjIdtaGm6k0VwWlK-oSzHnhP7ZmzN76sDubenAnjqwawdF8_7J_rAbsHtW_Au9AJ9XAEsgS8BksysJOuxCQjfbLob_2P8F3QGXgA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2491949814</pqid></control><display><type>article</type><title>Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms</title><source>Elsevier ScienceDirect Journals</source><creator>Pronier, Charlotte ; Gacouin, Arnaud ; Lagathu, Gisèle ; Le Tulzo, Yves ; Tadié, Jean-Marc ; Thibault, Vincent</creator><creatorcontrib>Pronier, Charlotte ; Gacouin, Arnaud ; Lagathu, Gisèle ; Le Tulzo, Yves ; Tadié, Jean-Marc ; Thibault, Vincent</creatorcontrib><description>•Respiratory samples collected from ICU hospitalized patients are heterogeneous.•The virus-over-cell ratio in respiratory samples allows some standardization of influenza virus load measurement.•Standardized respiratory viral load could help predicting poor outcome in patients with acute respiratory distress syndrome. The link between influenza virus (IV) viral load (VL) in respiratory samples and disease severity is not clearly established. This study was designed to assess IV-VL in respiratory samples from flu patients admitted to intensive care unit (ICU). Patients admitted to ICU for IV infection, as documented by RT-PCR, with respiratory failure were included in the study during 5 flu-seasons (2014–2018). Routine ICU management parameters were recorded. Real-time amplification Ct-values for IV and cell GAPDH gene were measured in each respiratory sample collected at ICU admission. Among 105 included patients, 59 (56.1%) presented an acute respiratory distress syndrome (ARDS). The overall mortality was 21%. IV-load assessed by amplification Ct-values and virus-over-cell ratio (expressed as log10) in each respiratory sample ranged from 20 to 40 and −5.2–3.7, respectively, and did not differ according to the type of sample and IV-A or -B type. Cell richness was higher in samples from ARDS patients compared to non-ARDS (p = 0.0003) but no difference was noted for IV Ct-values. In ARDS-patients, IV Ct-values (p = 0.020) and the virus-per-cell ratio (p = 0.038) were significantly higher in sample from patients who eventually died compared to those who survived. These 2 parameters remain independently associated with mortality with an odd-ratio of 1.21 and 2.19, respectively (p &lt; 0.05). While IV-VL does not seem to predict disease evolution in ICU flu-patients, normalized measurement of IV-VL in respiratory samples could be useful in ARDS patients to identify patients at higher risk of mortality.</description><identifier>ISSN: 1386-6532</identifier><identifier>EISSN: 1873-5967</identifier><identifier>DOI: 10.1016/j.jcv.2021.104761</identifier><identifier>PMID: 33609934</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Cell number ; Life Sciences ; Microbiology and Parasitology ; Quantification ; Real-time RT-PCR ; Virology ; Virus shedding</subject><ispartof>Journal of clinical virology, 2021-03, Vol.136, p.104761-104761, Article 104761</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier B.V.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-afa59994ca2338493843432b95807af196a8f24afddc877c918fe6eadbefa5d53</citedby><cites>FETCH-LOGICAL-c430t-afa59994ca2338493843432b95807af196a8f24afddc877c918fe6eadbefa5d53</cites><orcidid>0000-0002-7604-4849 ; 0000-0003-0239-9900 ; 0000-0001-6517-2901</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1386653221000287$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33609934$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03156480$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Pronier, Charlotte</creatorcontrib><creatorcontrib>Gacouin, Arnaud</creatorcontrib><creatorcontrib>Lagathu, Gisèle</creatorcontrib><creatorcontrib>Le Tulzo, Yves</creatorcontrib><creatorcontrib>Tadié, Jean-Marc</creatorcontrib><creatorcontrib>Thibault, Vincent</creatorcontrib><title>Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms</title><title>Journal of clinical virology</title><addtitle>J Clin Virol</addtitle><description>•Respiratory samples collected from ICU hospitalized patients are heterogeneous.•The virus-over-cell ratio in respiratory samples allows some standardization of influenza virus load measurement.•Standardized respiratory viral load could help predicting poor outcome in patients with acute respiratory distress syndrome. The link between influenza virus (IV) viral load (VL) in respiratory samples and disease severity is not clearly established. This study was designed to assess IV-VL in respiratory samples from flu patients admitted to intensive care unit (ICU). Patients admitted to ICU for IV infection, as documented by RT-PCR, with respiratory failure were included in the study during 5 flu-seasons (2014–2018). Routine ICU management parameters were recorded. Real-time amplification Ct-values for IV and cell GAPDH gene were measured in each respiratory sample collected at ICU admission. Among 105 included patients, 59 (56.1%) presented an acute respiratory distress syndrome (ARDS). The overall mortality was 21%. IV-load assessed by amplification Ct-values and virus-over-cell ratio (expressed as log10) in each respiratory sample ranged from 20 to 40 and −5.2–3.7, respectively, and did not differ according to the type of sample and IV-A or -B type. Cell richness was higher in samples from ARDS patients compared to non-ARDS (p = 0.0003) but no difference was noted for IV Ct-values. In ARDS-patients, IV Ct-values (p = 0.020) and the virus-per-cell ratio (p = 0.038) were significantly higher in sample from patients who eventually died compared to those who survived. These 2 parameters remain independently associated with mortality with an odd-ratio of 1.21 and 2.19, respectively (p &lt; 0.05). While IV-VL does not seem to predict disease evolution in ICU flu-patients, normalized measurement of IV-VL in respiratory samples could be useful in ARDS patients to identify patients at higher risk of mortality.</description><subject>Cell number</subject><subject>Life Sciences</subject><subject>Microbiology and Parasitology</subject><subject>Quantification</subject><subject>Real-time RT-PCR</subject><subject>Virology</subject><subject>Virus shedding</subject><issn>1386-6532</issn><issn>1873-5967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kcFvFCEYxYmxsbX6B3gxHPUwKwwMA_HUNGqbbGJi2jP5lvmwrDPDCLNjtn-9bKb26IEAX37vBd4j5B1nG864-rTf7N2yqVnNy122ir8gF1y3omqMal-Ws9CqUo2oz8nrnPeM8UbI9hU5F0IxY4S8IPYH5ikkmGM60tvR9wccH4EuZdTTPkJHIVOgA6RfmGj0dIox0SnFn2PMIdMw0gnmgOOc6Z8wP9CMCyak-ThMcxzyG3Lmoc_49mm_JPdfv9xd31Tb799ur6-2lZOCzRV4aIwx0kEthJamLCFFvTONZi14bhRoX0vwXed02zrDtUeF0O2wKLtGXJKPq-8D9HZKoTz4aCMEe3O1tacZE7xRUrOFF_bDypZv_D5gnu0QssO-hxHjIdtaGm6k0VwWlK-oSzHnhP7ZmzN76sDubenAnjqwawdF8_7J_rAbsHtW_Au9AJ9XAEsgS8BksysJOuxCQjfbLob_2P8F3QGXgA</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Pronier, Charlotte</creator><creator>Gacouin, Arnaud</creator><creator>Lagathu, Gisèle</creator><creator>Le Tulzo, Yves</creator><creator>Tadié, Jean-Marc</creator><creator>Thibault, Vincent</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-7604-4849</orcidid><orcidid>https://orcid.org/0000-0003-0239-9900</orcidid><orcidid>https://orcid.org/0000-0001-6517-2901</orcidid></search><sort><creationdate>20210301</creationdate><title>Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms</title><author>Pronier, Charlotte ; Gacouin, Arnaud ; Lagathu, Gisèle ; Le Tulzo, Yves ; Tadié, Jean-Marc ; Thibault, Vincent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-afa59994ca2338493843432b95807af196a8f24afddc877c918fe6eadbefa5d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cell number</topic><topic>Life Sciences</topic><topic>Microbiology and Parasitology</topic><topic>Quantification</topic><topic>Real-time RT-PCR</topic><topic>Virology</topic><topic>Virus shedding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pronier, Charlotte</creatorcontrib><creatorcontrib>Gacouin, Arnaud</creatorcontrib><creatorcontrib>Lagathu, Gisèle</creatorcontrib><creatorcontrib>Le Tulzo, Yves</creatorcontrib><creatorcontrib>Tadié, Jean-Marc</creatorcontrib><creatorcontrib>Thibault, Vincent</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Journal of clinical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pronier, Charlotte</au><au>Gacouin, Arnaud</au><au>Lagathu, Gisèle</au><au>Le Tulzo, Yves</au><au>Tadié, Jean-Marc</au><au>Thibault, Vincent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms</atitle><jtitle>Journal of clinical virology</jtitle><addtitle>J Clin Virol</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>136</volume><spage>104761</spage><epage>104761</epage><pages>104761-104761</pages><artnum>104761</artnum><issn>1386-6532</issn><eissn>1873-5967</eissn><abstract>•Respiratory samples collected from ICU hospitalized patients are heterogeneous.•The virus-over-cell ratio in respiratory samples allows some standardization of influenza virus load measurement.•Standardized respiratory viral load could help predicting poor outcome in patients with acute respiratory distress syndrome. The link between influenza virus (IV) viral load (VL) in respiratory samples and disease severity is not clearly established. This study was designed to assess IV-VL in respiratory samples from flu patients admitted to intensive care unit (ICU). Patients admitted to ICU for IV infection, as documented by RT-PCR, with respiratory failure were included in the study during 5 flu-seasons (2014–2018). Routine ICU management parameters were recorded. Real-time amplification Ct-values for IV and cell GAPDH gene were measured in each respiratory sample collected at ICU admission. Among 105 included patients, 59 (56.1%) presented an acute respiratory distress syndrome (ARDS). The overall mortality was 21%. IV-load assessed by amplification Ct-values and virus-over-cell ratio (expressed as log10) in each respiratory sample ranged from 20 to 40 and −5.2–3.7, respectively, and did not differ according to the type of sample and IV-A or -B type. Cell richness was higher in samples from ARDS patients compared to non-ARDS (p = 0.0003) but no difference was noted for IV Ct-values. In ARDS-patients, IV Ct-values (p = 0.020) and the virus-per-cell ratio (p = 0.038) were significantly higher in sample from patients who eventually died compared to those who survived. These 2 parameters remain independently associated with mortality with an odd-ratio of 1.21 and 2.19, respectively (p &lt; 0.05). While IV-VL does not seem to predict disease evolution in ICU flu-patients, normalized measurement of IV-VL in respiratory samples could be useful in ARDS patients to identify patients at higher risk of mortality.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33609934</pmid><doi>10.1016/j.jcv.2021.104761</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-7604-4849</orcidid><orcidid>https://orcid.org/0000-0003-0239-9900</orcidid><orcidid>https://orcid.org/0000-0001-6517-2901</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1386-6532
ispartof Journal of clinical virology, 2021-03, Vol.136, p.104761-104761, Article 104761
issn 1386-6532
1873-5967
language eng
recordid cdi_hal_primary_oai_HAL_hal_03156480v1
source Elsevier ScienceDirect Journals
subjects Cell number
Life Sciences
Microbiology and Parasitology
Quantification
Real-time RT-PCR
Virology
Virus shedding
title Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A52%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Respiratory%20Influenza%20viral%20load%20as%20a%20marker%20of%20poor%20prognosis%20in%20patients%20with%20severe%20symptoms&rft.jtitle=Journal%20of%20clinical%20virology&rft.au=Pronier,%20Charlotte&rft.date=2021-03-01&rft.volume=136&rft.spage=104761&rft.epage=104761&rft.pages=104761-104761&rft.artnum=104761&rft.issn=1386-6532&rft.eissn=1873-5967&rft_id=info:doi/10.1016/j.jcv.2021.104761&rft_dat=%3Cproquest_hal_p%3E2491949814%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2491949814&rft_id=info:pmid/33609934&rft_els_id=S1386653221000287&rfr_iscdi=true